Orthopedic, Prosthetic & Surgical Appliances & Supplies

AGM/EGMJun 4, 2026, 04:37 PM

Regentis Biomaterials Ltd. Announces Annual General Meeting on July 2, 2026

AI Summary

Regentis Biomaterials Ltd. has issued a Notice and Proxy Statement for its Annual General Meeting of Shareholders scheduled for July 2, 2026. The meeting agenda includes the re-election of directors, ratification of external director appointments, approval of stock option grants and warrant issuances to directors, adoption of a compensation policy, and the re-appointment of auditors. Shareholders of record as of June 9, 2026, are entitled to vote.

Key Highlights

Regentis Biomaterials Ltd. to hold Annual General Meeting on July 2, 2026.
Agenda includes re-election of directors Ehud Geller and Efraim Cohen-Arazi.
Proposal to ratify election of external directors Pini Ben Elazar and Susan Alpert.
Seeking approval for stock option grants to external directors Pini Ben Elazar and Susan Alpert (24,826 options each).
Seeking approval for stock option grants to serving directors Jeff Dykan, Keith Valentine, and Efraim Cohen-Arazi (24,826 options each).
Proposal to approve a top-up option grant of 8,313 options to Pini Ben-Elazar.
Proposal to approve issuance of warrants to Dr. Ehud Geller (31,250 shares) and Mr. Jeff Dykan (12,500 shares).
Proposal to approve adoption of the Company’s Compensation Policy.
Seeking re-appointment of Deloitte Israel & Co. as independent auditors for 2026.

View SEC Filing

RGNT

Orthopedic, Prosthetic & Surgical Appliances & Supplies

REGENTIS BIOMATERIALS LTD.

Price Impact